Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LW402 in moderate-to-severe atopic dermatitis
NCT07186387Phase 2Completed
- Sponsor
- Shanghai Longwood Biopharmaceuticals Co., Ltd.
- Start
- May 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lw402 in atopic dermatitis (AD), sponsored by Shanghai Longwood Biopharmaceuticals Co., Ltd.. Started May 2023; status: completed.
02
Drugs
lw402
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT07186387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07186387.